登录

Yizhun Intelligent Closes on ¥100 million Series B Funding Round

作者: Mailman 2020-03-20 12:36
医准智能
http://www.yizhun-ai.com
企业数据由 动脉橙 提供支持
人工智能辅助医疗影像诊断系统研发商 | 战略融资 | 运营中
中国-北京
2023-01-13
巨峰科创
查看

According to PEdaily.cn, Beijing-based Yizhun Intelligent Technology Co., Ltd. ("Yizhun Intelligent") has closed its Series B financing of nearly 100 million yuan, led by Sanmei Investment, with participation from Xiao Miao Langcheng Capital and existing investors, including Qingsong Fund and The Hina Group.


Proceeds of this financing will be used for research and development to expand Yizhun Intelligent's existing AI product line, and realize the coverage of AI-driven diagnosis system from single organ to diseases in a single site. 


In addition, Yizhun Intelligent will create AI products for specific diseases based on CT, MR, mammary molybdenum target machine, common X-ray machine, ultrasound and other imaging equipment. In addition, the company will also provide the customized image-recognition system for strategic partners with differentiated development and upgrading that meet the precise requirements in the application scenarios.


Founded in November 2017, Yizhun Intelligent is an AI & Robotics company focusing on diagnostic imaging. The company is deeply committed to the clinical front line, and at the same time, it collaborates with IBM Watson to build the medical image AI research platform (Darwin intelligent research platform). Yizhun Intelligent's products have been sold in more than 400 hospitals in China.


By virtue of AI technology of diagnostic imaging in the lung, Yizhun Intelligent launched the "AI+CT" diagnosis system for the coronavirus disease in just two weeks. Through the installation of servers and online upgrade, it helped dozens of users to implement the system, which greatly relieved the diagnostic pressure of imaging departments around.


>>>>

About The Hina Group


Since The Hina Group's founding in 2003, it has become one of China's leading cross border investment banking and private equity firms. Its team of over 50 professionals cooperates through its offices in Beijing, Shanghai, and San Francisco.


>>>>

About Qingsong Fund


Founded in June 2012, Qingsong Fund is an early venture capital firm specializing in investment in education, social networking, consumerism, innovation, technology and applications. It manages four RMB funds with a total value of about RMB 2 billion. So far, it has invested in more than 140 companies.

相关赛道 医疗信息化
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

KFBIO Closes on Series B Funding Round

DEEP INFORMATICS++ Closes ¥100M Series B Funding Round

Lead Medical Snares ¥10M in Series A2 Financing

HealAI Snares ¥10M in Series A Round

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

【首发】外科医疗器械公司雷盛医疗完成数千万A轮融资

2020-03-20
下一篇

Biotechnology Company Matridx Completes ¥100M Pre-A Round of Financing

2020-03-20